Investing.com - Nighthawk Biosciences (NYSE: NHWK) reported third quarter EPS of $-0.5000, $0.31 worse than the analyst estimate of $-0.1900. Revenue for the quarter came in at $723.13K versus the consensus estimate of $130K.
Nighthawk Biosciences's stock price closed at $0.4400. It is down -28.4100% in the last 3 months and down -70.9900% in the last 12 months.
Nighthawk Biosciences saw positive EPS revisions and negative EPS revisions in the last 90 days. See Nighthawk Biosciences's stock price’s past reactions to earnings here.
According to InvestingPro, Nighthawk Biosciences's Financial Health score is "fair performance".
Check out Nighthawk Biosciences's recent earnings performance, and Nighthawk Biosciences's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar